Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Gasperini

Showing results (41-50 of 203) with videos related to

Pageof 21
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2025
How premorbid structural reserve affects disability accrual in multiple sclerosisElena Barbuti, Luca Prosperini, Serena Ruggieri, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2024
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trialsValeria Pozzilli, Shalom Haggiag, Massimiliano Di Filippo, et al.
BMC Neurology|October 15, 2009
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective studyEmilia Sbardella, Valentina Tomassini, Claudio Gasperini, et al.
Journal of Neurology|September 10, 2005
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosisValentina Tomassini, Andrea Paolillo, Pierluigi Russo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2011
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI studyPatrizia Pantano, Silvia Bernardi, Emanuele Tinelli, et al.
Journal of Neurology|February 1, 2025
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinionMassimo Filippi, Maria Pia Amato, Carlo Avolio, et al.
Journal of Neurology|June 29, 2023
The added value of spinal cord lesions to disability accrual in multiple sclerosisSerena Ruggieri, Luca Prosperini, Maria Petracca, et al.
Journal of the Neurological Sciences|September 2, 2011
Efficacy and safety of subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: further outcomes from the IMPROVE studyNicola De Stefano, Maria Pia Sormani, Bettina Stubinski, et al.
Journal of Neurology|May 27, 2025
Personalized therapy in multiple sclerosis: an Italian Delphi consensusClaudio Gasperini, Diego Centonze, Antonella Conte, et al.
Annals of Neurology|March 1, 2013
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosisValerio Chiurchiù, Maria Teresa Cencioni, Elisa Bisicchia, et al.
Pageof 21

Showing results (41-50 of 203) with videos related to

Sort By:
Pageof 21
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2025
How premorbid structural reserve affects disability accrual in multiple sclerosisElena Barbuti, Luca Prosperini, Serena Ruggieri, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2024
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trialsValeria Pozzilli, Shalom Haggiag, Massimiliano Di Filippo, et al.
BMC Neurology|October 15, 2009
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective studyEmilia Sbardella, Valentina Tomassini, Claudio Gasperini, et al.
Journal of Neurology|September 10, 2005
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosisValentina Tomassini, Andrea Paolillo, Pierluigi Russo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2011
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI studyPatrizia Pantano, Silvia Bernardi, Emanuele Tinelli, et al.
Journal of Neurology|February 1, 2025
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinionMassimo Filippi, Maria Pia Amato, Carlo Avolio, et al.
Journal of Neurology|June 29, 2023
The added value of spinal cord lesions to disability accrual in multiple sclerosisSerena Ruggieri, Luca Prosperini, Maria Petracca, et al.
Journal of the Neurological Sciences|September 2, 2011
Efficacy and safety of subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: further outcomes from the IMPROVE studyNicola De Stefano, Maria Pia Sormani, Bettina Stubinski, et al.
Journal of Neurology|May 27, 2025
Personalized therapy in multiple sclerosis: an Italian Delphi consensusClaudio Gasperini, Diego Centonze, Antonella Conte, et al.
Annals of Neurology|March 1, 2013
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosisValerio Chiurchiù, Maria Teresa Cencioni, Elisa Bisicchia, et al.
Pageof 21